US Stock MarketDetailed Quotes

NTLA Intellia Therapeutics

Watchlist
  • 26.090
  • -1.270-4.64%
Close Jul 18 16:00 ET
  • 26.370
  • +0.280+1.07%
Post 19:11 ET
2.52BMarket Cap-4858P/E (TTM)

Intellia Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2023/FY
Stock NameRevenueRatio
Development of genome editing-based therapies36.28M100.00%
Region Currency:USD
2023/FY
Stock NameRevenueRatio
United States36.28M100.00%

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Gene Editing
Gene Editing
Intraday-0.76%
ARK Holdings
ARK Holdings
Intraday-0.79%